What Is My Manufacturing Business Worth? A 2026 Step-by-Step Self-Estimate

‘What is my manufacturing business worth?’ is the most common question we hear from owners 12-36 months out from a potential exit. And it’s the question with the most badly-calibrated answers in the trade press. Every search result returns generic advice (‘multiply your EBITDA by 6’) that doesn’t survive 60 seconds of buyer-side scrutiny. The real answer depends on sub-vertical (machine shop versus contract manufacturer versus precision machining versus aerospace versus medical device), size band ($500K-$2M EBITDA versus $5-25M versus $25M+), capital intensity (4-7% maintenance capex is typical and meaningfully reduces underwriteable cash flow), customer concentration (25%/40%/50% thresholds), recurring revenue mix (PO-only versus LTAs), certifications (ISO 9001, AS9100, NADCAP, ISO 13485, FDA), and the depth of the buyer pool actually willing to write a check at your size.

This guide walks you through a step-by-step self-estimate process used by lower middle-market manufacturing buyers in 2026. We’ll cover how to calculate normalized EBITDA and SDE correctly, how to identify your sub-vertical and the corresponding multiple range, how to apply size and concentration adjusters, how to normalize for capital intensity, and how to translate the multiple into actual after-tax proceeds. By the end you’ll have a defensible range — not a single number — that you can stress-test against actual buyer conversations.

The framework draws on direct work with 76+ active U.S. lower middle-market buyers — including 38 firms (50% of the network) with explicit manufacturing mandates. These buyers include manufacturing-focused PE platforms (Audax Industrial Services, Industrial Growth Partners, GenNx360 Capital Partners, Trive Capital, Mason Wells, Wynnchurch Capital, Argosy Capital, Sterling Group, Cortec Group, GTCR’s industrials practice, Genstar Capital industrial investments, Carlyle Industrials, Bain Capital Industrials, Onex industrial investments), public strategic consolidators (NYSE: APi Group [APG], NYSE: Watsco [WSO], NYSE: Comfort Systems USA [FIX], NYSE: Roper Technologies [ROP], NASDAQ: HEICO [HEI], NYSE: Atkore [ATKR]), family offices with industrial mandates, and search funders / independent sponsors. We’re a buy-side partner. The buyers pay us when a deal closes — not you.

One realistic note before you start. If you read this article and produce a self-estimate of $18M for your business, that’s a working hypothesis — not a number to anchor expectations on with your spouse, your CPA, or your succession plan. Real valuations live in a 25-35% range around any point estimate, and they shift based on which buyers see the business, what your books look like under QoE scrutiny, and what the deal structure ends up being (asset versus stock, working capital peg, seller financing, earnout). Use the self-estimate as a starting hypothesis, then validate it against actual buyer feedback before treating it as a number.

“Most owners self-estimate by Googling ‘manufacturing EBITDA multiple’ and multiplying their reported EBITDA by 7. That number is wrong on three layers: wrong metric (EBITDA vs SDE for owner-operated shops), wrong baseline (reported vs cash EBITDA), and wrong multiple (industry-wide median vs your specific sub-vertical and size band). The right self-estimate produces a range, not a number, and is grounded in your sub-vertical, your concentration, your certifications, and which of the 38 manufacturing-focused buyers in the LMM universe would actually look at your business.”

Key Takeaways

• 5-step self-estimate framework: normalize earnings, identify sub-vertical multiple range, apply size adjuster, apply concentration and recurring revenue adjusters, subtract debt and adjust for working capital.
• Sub-vertical multipliers in 2026: machine shop 3-5x SDE, contract manufacturer 5-7x EBITDA, precision machining 6-8x EBITDA, aerospace 7-10x EBITDA, medical device 8-12x EBITDA.
• Use SDE below $1.5M of normalized earnings; use EBITDA above $1.5M with real second-tier management in place. The wrong metric mis-prices the business by 25-30%.
• Maintenance capex normalization is mandatory: reported EBITDA − 3-year average maintenance capex (4-7% of revenue typical) = cash EBITDA, which is what disciplined buyers actually price.
• Customer concentration thresholds: under 15% no discount, 15-25% acknowledged, 25-40% triggers 0.5-1.5 turn discount, 40-50% pushes to earnout structures, 50%+ compresses 1.5-3 turns.
• Six common self-estimate mistakes: wrong metric (EBITDA vs SDE), ignoring maintenance capex, anchoring on industry-wide medians, mis-classifying recurring revenue, hiding concentration risk, forgetting working capital adjustment.

Step 1: Calculate normalized EBITDA (and SDE if you’re sub-$1.5M)

The starting point for any manufacturing valuation is normalized earnings. Reported EBITDA from your tax return or QuickBooks P&L is rarely the right number. You need normalized EBITDA: reported EBITDA plus add-backs (owner above-market compensation, family payroll without market-rate roles, one-time legal or ERP costs, equipment lease normalization) minus deductions (one-time gains, non-recurring revenue). The result is a defensible run-rate earnings number that survives QoE scrutiny.

How to calculate normalized EBITDA step by step. Start with net income from your most recent fiscal year tax return. Add back interest expense, federal and state income taxes, depreciation, and amortization (the standard EBITDA build). Then add documented add-backs: owner’s compensation above market rate (typically $100-200K of add-back if you pay yourself $300-400K and a market-rate plant manager would cost $150-180K), family members on payroll without market-rate roles, one-time legal fees from settled litigation, one-time ERP implementation costs, severance from documented one-time RIFs, owner’s personal vehicle/phone/travel with documentation, country club and similar discretionary perks. Subtract one-time gains (sale of equipment, insurance recoveries). The result is normalized EBITDA.

When to also calculate SDE. If your normalized EBITDA is below $1.5M and you are still functioning as the operating brain of the business (lead salesperson, lead estimator, lead programmer, customer relationship owner), buyers at your size will price using SDE, not EBITDA. SDE = normalized EBITDA + full owner compensation package (W-2 salary, bonus, benefits, all owner perks). The gap between EBITDA and SDE for owner-operated manufacturing businesses is typically $150-350K. A $700K EBITDA / $1M SDE machine shop priced at 4x SDE produces $4M of TEV; the same business priced at 4x EBITDA produces $2.8M of TEV. Pricing in the right metric matters by 30-40% of value at this size.

Use a 3-year average, not just TTM. Sophisticated manufacturing buyers will look at 3-year normalized EBITDA trend, not just trailing twelve months (TTM). TTM can be inflated by a one-time customer rush, a temporary commodity price spike, or deferred capex. A 3-year average smooths these effects and produces a more defensible run-rate. If your TTM is materially higher than your 3-year average, expect buyers to discount toward the average. If it’s materially lower, expect them to ask why and confirm it’s recoverable.

Step 2: Identify your sub-vertical and base multiple range

Manufacturing is not a single market with a single multiple. A 4,000-square-foot job-shop machine shop running general industrial work trades at a fundamentally different multiple than an AS9100-certified precision machining operation supplying Boeing, Lockheed, and Spirit AeroSystems. Sub-vertical identification is the second-most-important step in self-estimation. Get this wrong and your number is off by 50-200%.

General machine shops (no specialty certifications): 3-5x SDE for sub-$1M SDE, 4-6x EBITDA for $1-3M EBITDA. Hallmarks: 5-25 employees, $2-12M revenue, 8-15% EBITDA margins, broad customer mix without certification gating, owner often still doing customer-facing work or shop-floor labor. Buyers: SBA-financed individuals, search funders, independent sponsors, small strategic consolidators. Multiple compression below 3x SDE happens when the owner is the lead programmer or estimator and the business cannot survive a 30-day owner absence.

Contract manufacturers (CMs): 5-7x EBITDA for $2-10M EBITDA, 6-8x for $10M+ EBITDA. Hallmarks: defined production processes for established OEM customers, 60-80% recurring contracted revenue, multi-year supply agreements common, ISO 9001 baseline. Sub-categories include plastic injection molding, metal fabrication, electronic contract manufacturing (ECM), and turn-key assembly. Active LMM buyers: Trive Capital (multiple plastics platforms), Mason Wells (industrial CM), Wynnchurch Capital (metal fabrication), Argosy Capital (specialty CM), strategic consolidators like NYSE: Atkore (ATKR) and electrical product CMs. Capital intensity in injection molding can run 6-9% of revenue (heavy press and tooling investment), compressing multiples by 0.5 turn relative to lighter-asset CMs.

Precision machining (tight-tolerance, ISO 9001 minimum): 6-8x EBITDA for $3-15M EBITDA. Hallmarks: dimensional tolerances of 0.001” or better, served end-markets including medical instruments (non-implantable), industrial pumps, hydraulics, fluid power, automotive Tier-2. ISO 9001 is table stakes; ISO 13485 (medical) or AS9100 (aerospace) opens premium buyer pools. Active buyers: GenNx360 Capital Partners, Sterling Group, Industrial Growth Partners, strategic consolidators in fluid power (NYSE: Roper Technologies [ROP] subsidiaries, Helios Technologies, Parker Hannifin’s acquisition arm).

Aerospace contract manufacturers (AS9100 / NADCAP): 7-10x EBITDA for $3-25M EBITDA, 8-12x for $25M+. Hallmarks: AS9100D quality system, NADCAP accreditation for special processes (NDT, heat treat, chemical processing), Tier-1 OEM qualification (Boeing, Airbus, Lockheed, Northrop, Raytheon, Spirit AeroSystems), 60%+ recurring contracted revenue. Active aerospace LMM buyers: GenNx360, Audax Industrial, GTCR Industrials, Arlington Capital Partners, Greenbriar Equity Group, Cortec Group; strategic consolidators NASDAQ: HEICO (HEI), TransDigm, NYSE: Roper Technologies (ROP) subsidiaries. ITAR-restricted defense work adds 0.5-1 turn premium for U.S.-controlled buyers.

Medical device contract manufacturers (ISO 13485 / FDA registered): 8-12x EBITDA for $3-30M EBITDA. Hallmarks: FDA 21 CFR Part 820 quality system, ISO 13485 certification, 2-5 year regulatory submission and qualification cycles, 70%+ recurring contracted revenue, demographic-aging tailwind. Buyers: medical-focused PE (Linden Capital Partners, Riverside Healthcare, GTCR Healthcare, Bain Capital Healthcare) plus strategic acquirers consolidating medical CM. Capex intensity is higher (6-10% of revenue) but multiple expansion compensates.

Step 3: Apply the size premium / discount

Size matters in manufacturing M&A in non-linear ways. Multiples compress meaningfully below $2M EBITDA because the buyer pool shrinks dramatically: LMM PE platforms typically have minimum check sizes of $5-10M of equity per platform deal, which back into a $2-3M+ EBITDA threshold given typical multiples and capital structures. Below that, you’re in the search-funder / independent sponsor / SBA market, where capital structure mathematics force multiples down regardless of business quality.

Size premium / discount framework: Sub-$1M EBITDA: SDE multiples apply (3-5x typical), with maximum compression for owner-dependent businesses. $1-2M EBITDA: 0.5-1 turn discount versus the LMM range, dominant buyers are search funders and independent sponsors. $2-5M EBITDA: at-range LMM multiples, the entry point for disciplined LMM PE platforms. $5-15M EBITDA: 0.5-1 turn premium versus the bottom of the LMM range, full LMM PE competition. $15-50M EBITDA: 1-1.5 turn premium, upper LMM and lower middle-market PE compete, strategic premium often available. $50M+ EBITDA: full middle-market multiples, mega-cap PE and strategic consolidators dominate.

Why crossing $2-3M EBITDA changes everything. On a $1.8M EBITDA precision machining business, the realistic LMM PE buyer pool might be 8-12 firms. On a $3.5M EBITDA precision machining business, that pool expands to 20-30 firms with active interest. The expansion in buyer competition alone supports 0.5-1 turn of multiple expansion. Owners within $500K-$1M of the next size threshold often benefit from waiting 12-24 months to grow into the wider buyer pool — the multiple expansion plus the additional EBITDA growth often produces 30-60% more after-tax proceeds.

Worked example. A $2.4M EBITDA precision machining business in the 6-8x band at base, with the size adjuster applied: at $2.4M EBITDA you’re below the $3M+ threshold for full LMM PE competition, so apply a 0.5-1 turn discount to your sub-vertical base. Adjusted range: 5-7x. Then apply the next adjusters (concentration, recurring revenue, growth) to land on a final range. If you can grow EBITDA to $3.5M over 18 months while improving the qualitative metrics, you move from the 5-7x range to the 6-8x range — an additional turn of multiple on a higher EBITDA base.

Step 4: Apply the concentration and recurring revenue adjusters

Customer concentration is the single biggest qualitative adjuster in manufacturing M&A. The thresholds are well-known to any disciplined LMM buyer: under 15% concentration is treated as broadly diversified and earns no discount. 15-25% concentration is acknowledged but rarely repriced. 25-40% concentration triggers a 0.5-1.5 turn multiple discount and conversations about earnouts. 40-50% concentration pushes most LMM PE platforms to require an earnout structure tied to customer retention. Above 50% concentration, the deal compresses 1.5-3 turns and structure becomes heavily contingent.

How to calculate your true concentration. Pull 36-60 months of customer-by-customer revenue history from your ERP. Calculate revenue concentration in your top 1, top 3, top 5, and top 10 customers as a percentage of total revenue, on a trailing 12-month basis. Then layer in qualitative factors: long-term agreements (LTAs) with the top customers (multi-year contracts with volume commitments and pricing escalators reduce practical concentration risk), sole-source designations (sticky but more concentrated), customer-by-customer engineering relationships (key-person risk on the customer side), recent re-quotes or RFQs (signal of potential customer loss). Buyers will run all of this analysis during diligence anyway. Knowing your number going in protects you.

Recurring revenue is the multiple-expander. Buyers pay materially more for businesses where 60%+ of revenue is under multi-year contracted supply agreements with built-in volume commitments and pricing escalators than for businesses with the same EBITDA derived from project-based work or transactional purchase orders. The reasoning: contracted revenue is forecastable, recession-resistant within OEM cycles, and supports higher leverage in the buyer’s capital structure.

What counts as recurring versus repeat. Recurring revenue: multi-year LTAs with stated volume commitments, sole-source production parts on OEM bills of materials, aftermarket service parts where the OEM has installed-base equipment that needs replacement parts for 10-20+ years (the NASDAQ: HEICO [HEI] aerospace aftermarket thesis), repeat-order industrial commodity production (gaskets, fasteners, bearings, hydraulic components) with structural low-churn customer bases. NOT recurring: ‘repeat customers’ without contracted volume commitments (loyal, but can disappear in a single re-bid quarter), project-based work for the same customer (custom tooling, one-off fabrications, prototype runs), ad-hoc maintenance/repair/overhaul (MRO) without service contracts.

Combining the adjusters. A precision machining business with 70% recurring contracted revenue and 18% top-customer concentration trades at the top of its sub-vertical band (7-8x EBITDA). The same business with 30% recurring and 38% top-customer concentration trades 1.5-2.5 turns lower (5-6x EBITDA). On $4M EBITDA, that’s the difference between $28-32M of TEV and $20-24M of TEV — an $8M+ swing on the same earnings number. The adjusters are real money.

Step 5: Normalize for capital intensity and translate to TEV

Manufacturing is capital-intensive in ways that service businesses are not. A CNC machine shop, a plastic injection molder, a metal stamping operation, or an aerospace precision shop runs on equipment that depreciates in 5-15 years and requires ongoing replacement to maintain capacity. Reported EBITDA — which adds back depreciation — ignores the replacement obligation. Sophisticated buyers underwrite to cash EBITDA = reported EBITDA − 3-year average maintenance capex (excluding growth capex for new product lines or capacity expansion). The gap between reported and cash EBITDA is typically 15-30%.

Maintenance capex benchmarks. General machine shops: 3-5% of revenue. Precision machining: 5-7% of revenue. Plastic injection molding: 6-9% of revenue. Metal stamping and forming: 5-8% of revenue. Aerospace machining (AS9100): 5-8% of revenue plus 2-4% in tooling-specific spend. Medical device CMs: 6-10% of revenue with cleanroom infrastructure. Electronic CMs: 3-5% of revenue (lighter capex, but inventory-heavy). If your equipment is old and you’ve under-invested in maintenance capex for 3-5 years to inflate EBITDA, sophisticated buyers will catch it during QoE and re-price the deal.

Working through TEV math. Take your normalized EBITDA from Step 1. Apply your final multiple from Steps 2-4. The product is your TEV (total enterprise value): the price a buyer pays for the operating business cash-free and debt-free, with a working capital target. Subtract debt at close (equipment loans, capital leases treated as debt, any outstanding term loans). Add back excess cash retained by the seller. The result is your headline equity proceeds before working capital adjustment, transaction costs, and taxes.

Working capital adjustment. Manufacturing businesses carry significant working capital: typically 20-30% of revenue depending on sub-vertical. The buyer expects to receive normal operating working capital at close (inventory, receivables, payables). The peg is typically calculated as a trailing 12-24 month average. If you deliver above the peg, you get a positive adjustment; below, negative. On a $14M revenue business with a $3.5M working capital peg, an actual delivery of $3.2M produces a $300K downward adjustment to the equity check at close. Manufacturing owners who don’t negotiate the peg in the LOI can give up $300K-$2M+ at close on midsize deals.

After-tax proceeds and structure. Manufacturing M&A deals are typically structured as asset sales below ~$15M TEV (buyer prefers for liability and depreciation step-up) and as stock sales above (buyer accepts more risk for clean carry-forward of customer contracts and certifications). Asset sales create dual-tax exposure: ordinary income recapture on equipment and inventory (up to 37% federal + state), capital gains on goodwill (15-25% federal + state). Stock sales are pure long-term capital gains. State of residence matters: Texas, Florida, Tennessee, Nevada, Wyoming have 0% state capital gains; California, New York, Oregon, New Jersey have 8-13%+. On a $20M TEV deal, the gap between Texas and California is $1-2M of after-tax proceeds.

A worked self-estimate: $14M revenue precision machining business

Let’s walk through a complete self-estimate using a real example. Setup: a $14M revenue precision machining business in Ohio. AS9100 certified. Ten years in business. 35 employees. Plant manager and controller in place; owner functions as VP of sales and engineering. TTM net income $1.2M, depreciation $400K, interest $80K, taxes $300K. TTM reported EBITDA = $1.98M. Top customer (a Tier-1 aerospace OEM): 32% of revenue under a 3-year LTA expiring in 14 months. Top 3 customers: 58% of revenue. 65% of revenue under multi-year LTAs. 3-year average maintenance capex: $880K (6.3% of revenue). $700K of equipment loan debt. $3.4M of working capital.

Step 1 normalize EBITDA. Reported EBITDA $1.98M. Add-backs: $80K of owner above-market compensation (owner W-2 of $250K versus market-rate plant-and-sales manager at $170K), $25K of family payroll without market role (owner’s spouse on payroll for $50K, market role $25K), $40K one-time legal fees from settled customer dispute, $30K of personal vehicle/phone/perks, $35K one-time ERP migration cost. Total add-backs: $210K. Normalized TTM EBITDA = $2.19M. 3-year average normalized EBITDA = $2.05M (since TTM is slightly elevated). Use $2.05M as the working number.

Step 2 sub-vertical multiple range. AS9100-certified precision machining sits in the 7-10x EBITDA band. At $2.05M EBITDA, you’re below the $3M threshold for full LMM PE competition, so this is the lower end of that band’s applicability. Working starting range: 6.5-8.5x EBITDA.

Step 3 size adjuster. $2.05M EBITDA is sub-$3M, in search-funder / smaller LMM territory rather than full LMM PE competition. Apply a 0.5 turn discount versus the sub-vertical band. Adjusted range: 6-8x.

Step 4 concentration and recurring revenue adjusters. Top customer 32% concentration triggers a 0.75-1.25 turn discount. Top 3 customers at 58% adds another 0.25-0.5 turn discount. 65% recurring contracted revenue partially offsets with a +0.5 turn premium. Net adjuster: -0.5 to -1.25 turns. Adjusted range: 4.75-7.5x. The wide range reflects the binary nature of the concentration risk: a buyer who is comfortable underwriting a 32% concentration with strong LTAs pays toward the top; a disciplined buyer who reflexively discounts pays toward the bottom.

Step 5 capital intensity and TEV. Reported EBITDA $2.05M minus $880K maintenance capex = $1.17M cash EBITDA. Disciplined buyers anchor on cash EBITDA when deciding within the multiple range. Apply 4.75-7.5x to $2.05M EBITDA: TEV range $9.7M-$15.4M. Subtract $700K debt: equity range $9M-$14.7M before working capital adjustment. Working capital target ~$3.4M; assume neutral delivery. Estimate transaction costs at 1.5% ($150-225K), blended capital gains and ordinary income tax at 22% (asset sale structure with allocation to goodwill 75%, equipment 20%, non-compete 5%): net after-tax proceeds range $7-11M.

Step 6 stress-test and structure considerations. If the LTA expiring in 14 months can be renewed for another 3-year term during a sale process (or before going to market), the concentration discount narrows materially — the 4.75-7.5x range tightens to 5.5-7.5x. If the owner reduces personal involvement in sales over 12-18 months and adds a dedicated VP of Sales at $150K, the underlying business becomes more transferable and the multiple expands by another 0.25-0.5 turns. If a strategic consolidator (NASDAQ: HEICO [HEI] subsidiary, TransDigm acquisition arm) sees fit, a synergy premium of 0.5-1.5 turns is possible. Each lever pulled is real money: a $1M EBITDA business with 1 turn of multiple expansion is $1M+ of additional TEV.

Common manufacturing self-estimate mistakes

Mistake 1: using EBITDA when SDE is the right metric. An owner-operated $700K EBITDA machine shop priced at 4.5x EBITDA produces $3.15M of TEV. The same business with full SDE recognition (which captures the $200-300K of owner compensation that EBITDA leaves out) priced at 4x SDE produces $3.6M-$4M of TEV. Reporting in EBITDA at this size systematically underprices owner-operated businesses. The buyer pool at sub-$1M is SBA buyers and search funders who underwrite SDE; matching their metric protects your value.

Mistake 2: ignoring maintenance capex. Self-estimating a $2M EBITDA precision shop at 7.5x produces $15M of TEV in your head. But sophisticated buyers anchor on $1.2M cash EBITDA after $800K of maintenance capex, and apply a 6-7x multiple to that — producing $7.2-8.4M of TEV. The gap is dramatic. Bring a clean 5-year capex history and equipment-replacement plan to QoE and you protect against the worst of the discount; ignore it and the buyer’s analysis dominates yours.

Mistake 3: anchoring on Pitchbook headlines for the wrong size band. ‘Industrials traded at 8.4x in Q4’ describes the median across $25M+ EBITDA platform deals with strong recurring revenue and clean concentration profiles. It is not the multiple for a $2M EBITDA machine shop with 38% concentration. The most expensive owner self-estimate mistake in manufacturing is reading the right number for the wrong business.

Mistake 4: hiding customer concentration in the self-estimate. Many owners produce self-estimates assuming buyers won’t catch the 38% top-customer concentration. They will. Sophisticated buyers (Audax Industrial, Industrial Growth Partners, Sterling Group, GenNx360, Wynnchurch, Trive) request 36-60 months of customer-by-customer revenue history within the first week of LOI diligence. Self-estimates that pretend concentration doesn’t exist set up an LOI re-trade that can compress 1-2 turns of multiple. Honest self-estimates with the mitigation story (LTAs, sole-source designations, multi-program presence at the OEM) anchor better.

Mistake 5: mis-classifying recurring versus repeat revenue. Owners often self-estimate 80% recurring revenue when the actual figure under contract is 35%. The other 45% is ‘repeat’ — loyal customers who reorder regularly but without volume commitments. Buyers separate the two during diligence. Recurring contracted revenue at 35% with another 45% of repeat-but-not-contracted revenue produces a different multiple than 80% recurring contracted. Be honest with yourself in the self-estimate. The 0.5-1 turn of multiple difference is real.

Mistake 6: forgetting the working capital adjustment. Many owners self-estimate equity proceeds equal to TEV minus debt. They forget that the buyer expects to receive normal operating working capital at close. On a $14M revenue precision machining business with a $3.4M working capital target, an actual delivery of $3.1M produces a $300K downward adjustment. Most owners only realize this in the final week of close and feel cheated. The working capital adjustment is not a surprise — it’s standard. Build it into your self-estimate up front.

How to validate your self-estimate against actual buyer feedback

A self-estimate is a starting hypothesis, not a number to anchor expectations on. Real valuations live in a 25-35% range around any point estimate, and they shift based on which buyers see the business, what your books look like under QoE, and what the deal structure ends up being. The single highest-leverage way to validate a self-estimate is a structured conversation with someone who knows the actual manufacturing buyer pool — not a sell-side broker selling you a pitch, and not a generalist business broker without manufacturing depth.

What a real validation conversation looks like. (1) Walk through your sub-vertical, size band, customer concentration, recurring revenue mix, certifications, and capital intensity. (2) Get a realistic multiple range tied to your specific profile, not a generic industry median. (3) Identify the 3-5 specific buyer archetypes who would actually look at your business at this size and profile. (4) Understand which of your financial or operational metrics need 12-24 months of cleanup before going to market to protect the multiple. (5) Get a sense of structural risks (concentration, capex, owner dependency) that will compress the multiple unless mitigated.

What to avoid in ‘valuation’ conversations. Sell-side brokers selling you a 9-12 month auction process for an 8-12% fee. Generalist business brokers without sub-vertical-specific manufacturing depth. Online valuation calculators that don’t account for sub-vertical, certification, or capital intensity. CPA-prepared valuations that produce single point estimates without accounting for buyer-pool depth. Each of these has a use case (estate planning, SBA loan support, divorce litigation) but none of them produce a sale-relevant valuation grounded in the actual manufacturing buyer market.

How CT Acquisitions runs this conversation. We work directly with 76+ active U.S. lower middle-market buyers, including 38 firms with explicit manufacturing mandates: Audax Industrial Services, Industrial Growth Partners, GenNx360 Capital Partners, Trive Capital, Mason Wells, Wynnchurch Capital, Argosy Capital, Sterling Group, Cortec Group, GTCR Industrials, Genstar Capital industrial investments, Carlyle Industrials, Bain Capital Industrials, Onex industrial investments, family offices with manufacturing mandates, public consolidators (NYSE: APi Group [APG], Watsco [WSO], Comfort Systems [FIX], Roper [ROP], NASDAQ: HEICO [HEI], NYSE: Atkore [ATKR]), and search funders/independent sponsors. Buyers pay us when a deal closes. You pay nothing — no retainer, no contract. A 30-minute call gives you a real read on which buyers in our network would actually look at your business, what they’d realistically pay, and what 12-24 months of preparation would change.

When to use a paid third-party manufacturing valuation

Paid third-party valuations are useful for specific purposes — not always for sale planning. Three situations where a paid manufacturing valuation is worth $8-25K: (1) estate planning under IRS Section 409A or 706 (gift, estate, GRAT, intentional grantor trust). (2) ESOP transition requiring a fairness opinion compliant with DOL standards. (3) Shareholder litigation, marital dissolution, or other legal proceedings requiring a credentialed appraisal.

Credentials and firms that matter for manufacturing. ASA (Accredited Senior Appraiser), ABV (Accredited in Business Valuation), CVA (Certified Valuation Analyst). For manufacturing-specific work, Mercer Capital, Empire Valuation Consultants, the valuation arms of Plante Moran, BDO, Crowe, RSM, Wipfli, and Eide Bailly all maintain manufacturing benches with sub-vertical experience. Generalist appraisers without manufacturing depth produce single-point estimates that miss the sub-vertical premium and capital intensity nuance — useful for legal compliance, not for sale planning.

When NOT to pay for a credentialed appraisal. If you’re 12-24 months out from a potential sale and want a realistic working estimate, a credentialed appraisal is overkill. The credentialed report produces a standardized point estimate; the buyer-grounded conversation produces a range tied to actual buyer appetite, sub-vertical multiples, and structural mechanics. The latter is what you actually need for planning decisions: should I wait to grow into a higher size band? Should I diversify customer concentration first? Should I get AS9100 certified before going to market? Credentialed reports don’t answer those questions.

Combining the two for maximum information. If you’re doing serious estate or succession planning, the right approach is often a credentialed valuation for the legal/tax purpose plus a buy-side conversation for the sale-planning purpose. The two produce different outputs (point estimate versus range; standardized methodology versus buyer-pool-grounded analysis) and serve different decisions. Treating them as substitutes leaves money on the table.

Industry data sources for manufacturing valuation benchmarking

Five data sources sophisticated buyers actually use to triangulate manufacturing multiples in 2026. (1) GF Data DealStats: quarterly multiple data on completed LMM transactions, segmented by industry and size. (2) BVR DealStats: M&A multiples database with sub-vertical breakdowns. (3) Pitchbook industrials reports: aggregated PE deal flow and multiples across LMM and middle market. (4) Trade association data: AMT (Association for Manufacturing Technology) economic reports, NTMA (National Tooling and Machining Association) member surveys, PMA (Precision Metalforming) industry data, MAPI (Manufacturers Alliance) economic outlook, NAM (National Association of Manufacturers). (5) Public 10-K disclosures from serial industrial acquirers: NASDAQ: HEICO (HEI), NYSE: Atkore (ATKR), NYSE: Roper Technologies (ROP), TransDigm, NYSE: APi Group (APG).

What each source tells you and where it’s weak. GF Data DealStats: best for LMM multiples by size band; weak on sub-vertical specificity within manufacturing. BVR DealStats: deeper sub-vertical breakdowns; weaker recent-deal coverage. Pitchbook: best for aggregate market trends; weak on individual deal specifics in LMM. Trade association data: useful for operational benchmarks (gross margin, revenue per employee, on-time delivery, first-pass yield) but rarely publish multiples directly. Public 10-Ks: precise on individual deal metrics but represent the strategic/synergy multiple band, not the typical LMM PE band.

Government and economic data for context. U.S. Bureau of Labor Statistics (BLS) manufacturing employment and wage data is useful for benchmarking labor costs as a percentage of revenue. U.S. Bureau of Economic Analysis (BEA) GDP-by-industry data tracks manufacturing sector performance. Federal Reserve industrial production index tracks utilization and capacity. Census Bureau Annual Survey of Manufactures (ASM) provides detailed sub-vertical financial data. None of these directly inform multiples, but they give you the macroeconomic context buyers use to underwrite forward-looking projections.

How to triangulate. Start with the sub-vertical multiple range from this guide (or BVR/Pitchbook). Apply size adjuster from GF Data. Apply concentration and recurring revenue adjusters based on your specific profile. Cross-reference recent strategic deals from public 10-Ks for synergy-premium upside cases. Validate operational benchmarks against trade association data. The triangulated estimate is a defensible range, not a single number. Use it as the input to validation conversations with actual buyer-network professionals, not as the final word.

How to translate valuation into life proceeds (after-tax math)

TEV is not what you take home. Manufacturing M&A produces a layered set of deductions between TEV and net after-tax proceeds: debt payoff, transaction costs, taxes (federal, state, depreciation recapture on equipment, ordinary income on non-compete, capital gains on goodwill), seller financing carrying multi-year, and earnout payments contingent on post-close performance. A $20M TEV deal often produces $12-15M of cash at close, with another $2-4M in seller note collected over 7-10 years and $0-3M in earnout collected over 1-3 years.

Asset sale tax mechanics. Most manufacturing deals below ~$15M TEV are structured as asset sales (buyer prefers for liability protection and depreciation step-up). The seller’s tax exposure depends on asset allocation across categories (Form 8594): equipment and inventory are subject to ordinary income recapture (up to 37% federal + state); goodwill is subject to long-term capital gains (15-20% federal + state); non-compete is ordinary income to seller, deductible to buyer; consulting agreement is ordinary income spread over the consulting period. The split is negotiated, not given. A skilled tax attorney can shift $200K-$1M of after-tax proceeds in the seller’s favor through allocation negotiation on a $20M deal.

Stock sale mechanics for larger deals. Above ~$15-20M TEV, deals are more often structured as stock sales. The seller gets pure long-term capital gains treatment (15-20% federal + state) on the entire transaction. Buyer accepts more risk (carry-forward of all liabilities) but gets cleaner customer-contract and certification continuity. Stock sale structure typically nets the seller 10-20% more after-tax proceeds than an equivalent asset sale — one of the meaningful benefits of growing into the larger size band.

Section 1202 QSBS for C-corp businesses. If your manufacturing business is structured as a C-corporation and meets the qualifying small business stock (QSBS) tests — held 5+ years, original-issue stock, gross assets under $50M when issued, qualified trade/business including most manufacturing — you may qualify for up to $10M of capital gains exclusion under IRC Section 1202. On a $20M sale, that’s up to $2M of federal tax savings. Most LLCs and S-corps don’t qualify; if you’re considering a C-corp conversion 5+ years before sale, talk to a tax attorney 12+ months before going to market.

State of residence matters more than owners realize. Texas, Florida, Tennessee, Nevada, Wyoming: 0% state capital gains. Washington: 7% capital gains tax above threshold. Pennsylvania, Indiana, Michigan, Ohio: 3-5%. New York, New Jersey, Oregon: 8-11%. California: up to 13.3%. On a $20M deal, the gap between Texas and California can be $1.5-2M+ of after-tax proceeds. Some sellers strategically relocate before sale (must be a real, sustainable move — cosmetic relocations get challenged on residency). Plan the relocation 12-24 months before sale if it’s the right move; don’t do it cosmetically in the final 6 months.

When self-estimating tells you to wait, and when it tells you to sell now

A good self-estimate produces a planning decision, not just a number. If your self-estimate suggests $12M of net after-tax proceeds today and $18M of net after-tax proceeds with 18-24 months of preparation, the planning decision is clear: wait, prep, and exit at the higher number. If your self-estimate suggests minimal upside from preparation (because your business is already running well, your concentration is clean, your certifications are in place, your books are pristine), the planning decision is also clear: sell now. The self-estimate should drive the timing decision.

Signals that 18-24 months of preparation will pay off. (1) You’re within $500K-$1M of the next size threshold (sub-$3M EBITDA approaching $3M; sub-$10M EBITDA approaching $10M). (2) Customer concentration above 30%. (3) Recurring contracted revenue below 40%. (4) Missing a relevant certification (no ISO 9001 if you’re sub-precision; no AS9100 if you serve aerospace; no ISO 13485 if you serve medical). (5) Books on QuickBooks Online without monthly closes or CPA review. (6) Owner still functioning as lead salesperson, lead estimator, lead programmer, or lead customer relationship manager.

Signals that selling now is the right call. (1) Health issues forcing exit. (2) Co-owner conflict that can’t be resolved on a planning timeline. (3) Structural sub-vertical decline (e.g., a CM serving a single shrinking end-market). (4) Personal financial crisis requiring liquidity. (5) Strategic acquisition opportunity with a specific buyer at a premium synergy multiple. (6) Loss of a top customer that will permanently impair the business if not exited before contracts re-bid. In these cases, the discount of selling unprepared is smaller than the cost of trying to wait through a deteriorating situation.

The cost of misjudging the timing. Selling 18 months too early (before completing prep work) typically costs 1-3 turns of multiple — on $3M EBITDA, that’s $3-9M of TEV. Selling 18 months too late (after a customer loss, a regulatory issue, or a personal crisis) often costs 0.5-1.5 turns of multiple plus the structural impairment to the business. The right answer is to make the timing decision deliberately, with a self-estimate and validation in hand, not by default. The owners who realize the highest manufacturing multiples are the ones who plan the exit 18-36 months in advance.

Free tools and resources for manufacturing self-estimation

Free tools that produce credible self-estimates. (1) CT Acquisitions valuation calculator (linked at the end of this guide). (2) BVR’s free DealStats samples (limited free access to recent deal multiples). (3) IBISWorld manufacturing industry reports (often available through public library systems). (4) Trade association member surveys (AMT, NTMA, PMA, MAPI). (5) U.S. Census Bureau Annual Survey of Manufactures and Quarterly Financial Report.

Paid resources worth the investment for sophisticated self-estimates. GF Data DealStats subscription ($1,500-3,000/year) for direct access to LMM multiples by size and industry. BVR DealStats full subscription ($2,500-5,000/year) for sub-vertical breakdowns. Pitchbook subscription ($25K+/year, typically used by deal professionals only). For owners 12-24 months from sale, these are usually overkill — the sample data and trade association resources are sufficient for working estimates.

What free buy-side conversations add that no calculator can. The 38 manufacturing-focused buyers in our 76+ buyer network each have specific buy-box criteria: size band, sub-vertical, customer concentration tolerance, certification requirements, geographic preferences, growth-rate expectations. A conversation with someone who knows those criteria can identify which 3-5 buyers would actually look at your business in 60 seconds — something no calculator or industry report can do. The narrowed buyer pool is what determines your realistic multiple range, not the industry-wide median.

How to use this article as a self-estimate workbook. Read through Steps 1-5 above. Pull your tax returns and ERP customer-by-customer revenue history. Calculate normalized EBITDA (and SDE if sub-$1.5M). Identify your sub-vertical and base multiple range from Step 2. Apply the size, concentration, and recurring revenue adjusters in Steps 3-4. Normalize for capital intensity in Step 5. Translate to TEV, equity proceeds, and net after-tax proceeds. The output is a defensible range, not a number. Then validate with a free 30-minute call to a buy-side partner who knows the manufacturing buyer pool. The combination produces a planning-grade estimate that’s good enough to make the timing decision.

Conclusion

Self-estimating what your manufacturing business is worth is a 5-step process — not a single multiple multiplication. Calculate normalized EBITDA (or SDE if sub-$1.5M with owner-operator profile). Identify your sub-vertical and base multiple range (machine shop 3-5x SDE, contract manufacturer 5-7x EBITDA, precision machining 6-8x EBITDA, aerospace AS9100/NADCAP 7-10x EBITDA, medical device ISO 13485/FDA 8-12x EBITDA). Apply the size, concentration, and recurring revenue adjusters. Normalize for capital intensity. Translate to TEV, equity proceeds, and net after-tax proceeds. The output is a planning-grade range that drives the timing decision: wait and prep, or sell now. The owners who realize the highest manufacturing multiples are the ones who plan the exit 18-36 months in advance with self-estimates grounded in sub-vertical reality, not industry-wide medians. And if you want to validate your self-estimate against the 38 manufacturing-focused buyers in the LMM universe personally instead of running an auction, we’re a buy-side partner — the buyers pay us, not you, no contract required.

Frequently Asked Questions

What multiple of EBITDA does a manufacturing business sell for in 2026?

TEV/EBITDA multiples in 2026 cluster in three size bands per GF Data, BVR DealStats, and Pitchbook industrials: sub-$10M EBITDA = 4-7x, $10-50M EBITDA = 6-9x, $50M+ EBITDA = 7-12x. Sub-vertical and customer concentration shift you 1-3 turns inside those bands. Aerospace (AS9100/NADCAP) trades 7-10x; medical device (ISO 13485/FDA) trades 8-12x; commodity contract manufacturing trades 4-6x.

How do I calculate SDE for my owner-operated machine shop?

Start with net income from your tax return. Add back interest, taxes, depreciation, amortization (the EBITDA build). Then add owner’s W-2 salary, owner’s health insurance and benefits, owner’s vehicle and phone, family members on payroll without market-rate roles, owner’s personal travel/meals/perks, country club memberships. Subtract one-time gains, add back one-time expenses. The result is SDE. For owner-operated machine shops sub-$1.5M, SDE is the metric buyers underwrite, not EBITDA.

What is my contract manufacturing business worth?

Contract manufacturers (CMs) typically trade at 5-7x EBITDA for $2-10M EBITDA businesses, 6-8x for $10M+ EBITDA. Premium for: 70%+ recurring contracted revenue under multi-year LTAs, diversified customer base (top customer under 25%), ISO 9001+ certification, modern ERP discipline. Discount for: project-based revenue without LTAs, customer concentration above 30%, capital-intensive sub-categories like injection molding (capex 6-9% of revenue compresses 0.5 turn). Active LMM buyers: Trive Capital, Mason Wells, Wynnchurch, Argosy Capital.

What multiple does a precision machining business sell for?

Precision machining businesses (tight-tolerance, ISO 9001 minimum) trade at 6-8x EBITDA for $3-15M EBITDA. ISO 13485 (medical) or AS9100 (aerospace) certifications open premium buyer pools at 7-10x and 8-12x respectively. Active buyers: GenNx360 Capital Partners, Sterling Group, Industrial Growth Partners, plus strategic consolidators in fluid power (Roper Technologies subsidiaries, Helios Technologies, Parker Hannifin acquisition arm).

How does AS9100 certification affect aerospace manufacturer valuation?

AS9100D certification typically supports 7-10x EBITDA versus 4-7x for general machine shops — a 1-3 turn premium. NADCAP accreditation for special processes (NDT, heat treat, chemical processing) adds further premium. The reasoning: certification scarcity, OEM qualification cycles of 18-36 months that lock incumbents in, 60%+ recurring contracted revenue from Tier-1 OEMs (Boeing, Airbus, Lockheed, Northrop, Spirit AeroSystems). ITAR-restricted defense work adds another 0.5-1 turn for U.S.-controlled buyers.

What is a typical EBITDA multiple for a medical device CM?

Medical device contract manufacturers operating under FDA 21 CFR Part 820 with ISO 13485 certification trade at 8-12x EBITDA for $3-30M EBITDA businesses — the top of the manufacturing valuation range. Drivers: 2-5 year regulatory submission cycles creating customer lock-in, 70%+ recurring contracted revenue, demographic-aging tailwind. Buyers include medical-focused PE (Linden Capital Partners, Riverside Healthcare, GTCR Healthcare, Bain Capital Healthcare) plus strategic acquirers consolidating the medical CM market.

How do I account for capital intensity in my self-estimate?

Calculate 3-year average maintenance capex as a percentage of revenue (typical: 4-7% across most manufacturing sub-verticals). Subtract from reported EBITDA to derive cash EBITDA. Sophisticated buyers anchor on cash EBITDA, not headline EBITDA, when deciding within a multiple range. A $14M revenue, $2M reported EBITDA precision shop with $880K average maintenance capex (6.3%) underwrites at $1.12M cash EBITDA — a meaningful difference at 6.5x = $7.3M versus $13M of TEV.

How does customer concentration affect my manufacturing business value?

Under 15% concentration: no discount. 15-25%: acknowledged but rarely repriced. 25-40%: 0.5-1.5 turn discount and earnout conversations. 40-50%: most LMM PE platforms require an earnout structure tied to customer retention. 50%+: deal compresses 1.5-3 turns and structure becomes heavily contingent. Mitigations that protect the multiple: long-term agreements (3-5 year LTAs with volume commitments), sole-source designations, multi-program presence at the same OEM, ISO 9001/AS9100/ISO 13485 certifications creating customer switching costs.

Should I get a paid valuation before talking to buyers?

Only if you have a specific need: estate planning under Section 409A/706, ESOP transition with DOL fairness opinion, shareholder litigation, marital dissolution. For sale planning, a free 30-minute buy-side conversation produces more useful output than a $10-25K credentialed appraisal: realistic multiple range tied to your specific sub-vertical and size band, identification of 3-5 actual buyer archetypes, and clear guidance on what 12-24 months of preparation would change.

What is my $1M EBITDA machine shop really worth?

Sub-$1.5M EBITDA owner-operated machine shops are valued on SDE, not EBITDA. Calculate full SDE: $1M EBITDA + $250K of owner compensation/benefits/perks = $1.25M SDE. Apply a 3.5-4.5x SDE multiple typical for sub-$1.5M owner-operated machine shops with reasonable concentration and modest customer diversification. Result: $4.4-5.6M TEV. Subtract $200K of equipment loan debt and adjust working capital. Net equity proceeds before tax: $4.0-5.4M. After 1.5% transaction costs and 22% blended tax (asset sale): net after-tax proceeds $3.0-4.0M.

What documentation should I prepare before requesting a valuation?

36 months of tax returns and CPA-prepared financial statements. 36-60 months of customer-by-customer revenue history (top 25 customers minimum). Documented add-backs with line-item supporting receipts. Current fixed-asset register with model numbers, acquisition dates, accumulated depreciation, remaining useful life. 24-month working capital trend with category breakdowns. Current customer LTAs and supplier agreements. Quality certifications (ISO 9001, AS9100, ISO 13485, NADCAP). Equipment maintenance records. Organizational chart with key employees, tenure, comp, and replaceability.

When is the best time to sell my manufacturing business?

Wait if: you’re within $500K-$1M of the next size threshold; customer concentration above 30%; recurring contracted revenue below 40%; missing a relevant certification; books need 12-18 months of cleanup; you’re still the operating brain. Each gap closed pays back 0.5-2 turns of multiple. Sell now if: health forcing exit, partnership conflict, structural sub-vertical decline, strategic acquisition window with a specific premium buyer, or personal liquidity crisis. The right answer is a deliberate timing decision based on a self-estimate, not a default reaction.

How is CT Acquisitions different from a sell-side broker or M&A advisor?

We’re a buy-side partner, not a sell-side broker. Sell-side brokers represent you and charge you 8-12% of the deal (often $300K-$1M+) plus monthly retainers, run a 9-12 month auction process, and require 12-month exclusivity. We work directly with 76+ buyers — including 38 firms with explicit manufacturing mandates: Audax Industrial, Industrial Growth Partners, GenNx360, Trive, Mason Wells, Wynnchurch, Sterling Group, Argosy, Cortec, GTCR Industrials, family offices, and strategic consolidators — who pay us when a deal closes. You pay nothing. No retainer, no exclusivity, no contract until a buyer is at the closing table. We move faster (60-180 days from intro to close in many cases) because we already know which of the 38 manufacturing-focused buyers in the network would actually look at your business rather than running an auction to find one.

Sources & References

All claims and figures in this analysis are sourced from the publicly available references below.

1. https://www.sba.gov/funding-programs/loans/7a-loans
2. https://www.irs.gov/forms-pubs/about-form-8594
3. https://www.nam.org/
4. https://www.amtonline.org/
5. https://www.ntma.org/
6. https://www.bls.gov/iag/tgs/iag31-33.htm
7. https://www.bea.gov/data/gdp/gdp-industry
8. https://investors.atkore.com/financial-information/sec-filings